Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 3Central Nervous System Neoplasms 3Gliosarcoma 2Brain Neoplasms 2Sarcoma 1Oligodendroglioma 1Meningioma 1Hemangiopericytoma, Malignant 1Glioma 1Ependymoma 1Astrocytoma 1

Interventions

vatalanib 1Trabectedin 1Magnetic Resonance Spectroscopy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiopericytoma, Malignant × vatalanib × CNS × Clear all
NCT00348790 2018-10-26

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Northwestern University

Phase 2 Completed
25 enrolled 10 charts
CNSSarcoma

Hemangiopericytoma, Malignant, Brain Neoplasms, Meningioma, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡